IDEAS home Printed from https://ideas.repec.org/a/bla/ecaffa/v26y2006i3p24-32.html
   My bibliography  Save this article

Direct‐To‐Consumer Advertising (Dtca) Of Pharmaceuticals: An Updated Review Of The Literature And Debate Since 2003

Author

Listed:
  • Frank Auton

Abstract

The pharmaceutical sector is unusual amongst global regulated industries inasmuch as it is usually forbidden from advertising to the users of its products. This paper reports on research updating my 2003 review 2 of the evidence and arguments for and against the direct‐to‐consumer advertising (DTCA) of prescription drugs. It not only covers the two countries where significant DTCA is permitted (USA and New Zealand), but also the administrations in which there is active discussion of possibilities to ease or amend some of the current restrictions (Europe, Australia and Canada).

Suggested Citation

  • Frank Auton, 2006. "Direct‐To‐Consumer Advertising (Dtca) Of Pharmaceuticals: An Updated Review Of The Literature And Debate Since 2003," Economic Affairs, Wiley Blackwell, vol. 26(3), pages 24-32, September.
    • Handle: RePEc:bla:ecaffa:v:26:y:2006:i:3:p:24-32
    DOI: 10.1111/j.1468-0270.2006.00646.x
    as

    Download full text from publisher

    File URL: https://doi.org/10.1111/j.1468-0270.2006.00646.x
    Download Restriction: no
    File URL: https://libkey.io/10.1111/j.1468-0270.2006.00646.x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Glaeser, Edward L. & Ujhelyi, Gergely, 2010. "Regulating misinformation," Journal of Public Economics, Elsevier, vol. 94(3-4), pages 247-257, April.
    2. Eisenberg, Matthew D. & Avery, Rosemary J. & Cantor, Jonathan H., 2017. "Vitamin panacea: Is advertising fueling demand for products with uncertain scientific benefit?," Journal of Health Economics, Elsevier, vol. 55(C), pages 30-44.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:bla:ecaffa:v:26:y:2006:i:3:p:24-32. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Wiley Content Delivery (email available below). General contact details of provider: http://www.blackwellpublishing.com/journal.asp?ref=0265-0665 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.